{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Mesalamine potential adverse effects",
            "expectation": "若风险成立，应用高权重 refutes 边标注",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Infliximab potential adverse effects",
            "expectation": "若风险成立，应用高权重 refutes 边标注",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tocilizumab",
          "type": "Drug",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_loperamide",
          "type": "Drug",
          "label": "Loperamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_probiotics",
          "type": "Drug",
          "label": "Probiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_IL10",
          "type": "Target",
          "label": "Interleukin 10",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_TNF-alpha",
          "type": "Target",
          "label": "Tumor Necrosis Factor-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_IFN-gamma",
          "type": "Target",
          "label": "Interferon gamma",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_anti-inflammatory",
          "type": "Pathway",
          "label": "Anti-inflammatory Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_immunomodulation",
          "type": "Pathway",
          "label": "Immunomodulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_GI_disorder",
          "type": "Disease",
          "label": "Gastrointestinal Epithelial Barrier Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_mesalamine",
          "type": "Target",
          "label": "OffTarget_Mesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_mesalamine",
          "type": "Pathway",
          "label": "RiskPathway_Mesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_mesalamine",
          "type": "Phenotype",
          "label": "AdversePhenotype_Mesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "OffTarget_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "RiskPathway_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "OffTarget_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "RiskPathway_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "AdversePhenotype_Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Mesalamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Budesonide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Prednisone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Loperamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Probiotics",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_mesalamine",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知作用于抗炎介质"
        },
        {
          "source": "drug_infliximab",
          "target": "target_TNF-alpha",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "机制已广泛研究用于相关疾病"
        },
        {
          "source": "drug_adalimumab",
          "target": "target_TNF-alpha",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "与类似机制药物一致"
        },
        {
          "source": "drug_budesonide",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过调节抗炎反应的常识"
        },
        {
          "source": "drug_prednisone",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "具有广泛的免疫抑制作用"
        },
        {
          "source": "drug_ustekinumab",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响特定细胞因子通路"
        },
        {
          "source": "drug_tocilizumab",
          "target": "target_IL10",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "主要用于炎症相关性疾病"
        },
        {
          "source": "drug_methotrexate",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "作为抗炎药物的常见应用"
        },
        {
          "source": "drug_azathioprine",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于免疫调节的药物"
        },
        {
          "source": "drug_cyclosporine",
          "target": "target_IFN-gamma",
          "relation": "acts_on",
          "weight": 0.58,
          "agent": "Proponent",
          "rationale": "用于抑制免疫反应"
        },
        {
          "source": "drug_loperamide",
          "target": "disease_GI_disorder",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "用于对抗腹泻相关的GI病理"
        },
        {
          "source": "drug_probiotics",
          "target": "disease_GI_disorder",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "通过改善肠道微生物群"
        },
        {
          "source": "target_IL10",
          "target": "pathway_anti-inflammatory",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抗炎通路的核心成分"
        },
        {
          "source": "target_TNF-alpha",
          "target": "pathway_anti-inflammatory",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "关键的炎症介质"
        },
        {
          "source": "target_IFN-gamma",
          "target": "pathway_immunomodulation",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫调节的必要成分"
        },
        {
          "source": "pathway_anti-inflammatory",
          "target": "disease_GI_disorder",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "通过抑制炎症来改善症状"
        },
        {
          "source": "pathway_immunomodulation",
          "target": "disease_GI_disorder",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响免疫反应的通路"
        },
        {
          "source": "drug_mesalamine",
          "target": "n_ot_mesalamine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在未知的旁路作用"
        },
        {
          "source": "n_ot_mesalamine",
          "target": "n_rp_mesalamine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与潜在风险通路有关"
        },
        {
          "source": "n_rp_mesalamine",
          "target": "n_adv_mesalamine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良表型"
        },
        {
          "source": "n_adv_mesalamine",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若风险成立，将对假设形成反驳"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "副作用未完全了解"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在风险机制关联"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能产生不良反应"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险对假设产生反驳"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "靶向机制可能有缺陷"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路潜在的旁路"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致负面后果"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险的出现可能抵消效益"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": [
            {
              "topic": "Mesalamine potential adverse effects",
              "pro_nodes": [
                "H1"
              ],
              "con_nodes": [
                "n_adv_mesalamine"
              ],
              "note": "潜在不良反应与假设之间的冲突"
            }
          ]
        },
        "notes": "已完成对 Mesalamine 的安全性压力测试：以高权重 refutes 边连到假设"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": [
            {
              "topic": "Infliximab potential adverse effects",
              "pro_nodes": [
                "H2"
              ],
              "con_nodes": [
                "n_adv_infliximab"
              ],
              "note": "潜在不良反应与假设之间的冲突"
            }
          ]
        },
        "notes": "已完成对 Infliximab 的安全性压力测试：以高权重 refutes 边连到假设"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": [
      "急性方面的效应与长期潜在不良反应之间的方向性尚未消解",
      "与其他共同药物的潜在联合效应需进一步研究"
    ]
  }
}